Scientists have discovered that two main causes of AD amyloid-beta (A²) peptides and apolipoprotein E4 (apoE4) impair the growth of new neurons born in adult brains. What is more, they have identified drug treatments that can normalize the development of these cells even in the presence of A² or apoE4.